Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.
Launched by MASARYK UNIVERSITY · Sep 26, 2019
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
The study will commence following the Approval by The Ethics Research Committee. All patients admitted to our emergency department for trauma from the 1st of October 2019 to the 31st of January 2020 will be enrolled after fulfilling the inclusion criteria and in the absence of any exclusion criteria. Informed consent will be requested. Viscoelastic tests of coagulation will be performed on ROTEM® Delta and ClotPro® simultaneously. We will compare values of clotting time (CT), clot formation time (CFT), alfa angle, maximum clot firmness (MCF) and maximum lysis (ML) for test of extrinsic path...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age ≥18 years
- • polytrauma with Injury severity score ≥ 16
- Exclusion Criteria:
- • pregnancy
- • anticoagulant therapy
- • antiplatelet therapy
- • coagulation disorders
About Masaryk University
Masaryk University, located in Brno, Czech Republic, is a leading academic institution renowned for its commitment to advancing research and education in the life sciences and clinical fields. As a sponsor of clinical trials, the university leverages its extensive resources, including state-of-the-art laboratories and a multidisciplinary team of experts, to conduct innovative research that addresses critical health challenges. With a focus on ethical standards and regulatory compliance, Masaryk University aims to contribute to the development of new therapeutic approaches and improve patient outcomes through rigorous scientific inquiry and collaboration with healthcare partners.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brno, , Czechia
Patients applied
Trial Officials
Roman Gal, MD., PhD.
Study Chair
University Hospital Brno and Masaryk University Brno
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials